Stryker Co. (NYSE:SYK) Shares Bought by Wolff Financial Management LLC

Wolff Financial Management LLC increased its position in Stryker Co. (NYSE:SYK - Free Report) by 41.1% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 10,156 shares of the medical technology company's stock after acquiring an additional 2,957 shares during the period. Stryker comprises approximately 0.9% of Wolff Financial Management LLC's holdings, making the stock its 18th largest position. Wolff Financial Management LLC's holdings in Stryker were worth $3,041,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also added to or reduced their stakes in SYK. LA Financiere DE L Echiquier lifted its stake in Stryker by 2.7% during the 4th quarter. LA Financiere DE L Echiquier now owns 193,925 shares of the medical technology company's stock valued at $58,073,000 after acquiring an additional 5,113 shares during the period. Trivant Custom Portfolio Group LLC bought a new position in Stryker during the fourth quarter valued at approximately $2,634,000. Strategic Blueprint LLC boosted its holdings in Stryker by 15.0% in the fourth quarter. Strategic Blueprint LLC now owns 1,127 shares of the medical technology company's stock worth $338,000 after purchasing an additional 147 shares during the last quarter. Valley National Advisers Inc. grew its position in Stryker by 14.0% in the 4th quarter. Valley National Advisers Inc. now owns 399 shares of the medical technology company's stock worth $119,000 after purchasing an additional 49 shares during the period. Finally, BSW Wealth Partners raised its stake in Stryker by 4.8% during the 4th quarter. BSW Wealth Partners now owns 938 shares of the medical technology company's stock valued at $281,000 after buying an additional 43 shares during the last quarter. 77.09% of the stock is owned by institutional investors.

Analyst Ratings Changes

A number of equities research analysts have issued reports on the company. Canaccord Genuity Group upgraded Stryker from a "hold" rating to a "buy" rating and boosted their price target for the company from $315.00 to $360.00 in a research note on Wednesday, January 31st. Evercore ISI boosted their target price on shares of Stryker from $340.00 to $370.00 and gave the company an "outperform" rating in a research report on Thursday. StockNews.com upgraded shares of Stryker from a "hold" rating to a "buy" rating in a research report on Tuesday, January 23rd. Royal Bank of Canada reissued an "outperform" rating and set a $360.00 price objective on shares of Stryker in a research report on Thursday, February 15th. Finally, Canaccord Genuity Group raised Stryker from a "hold" rating to a "buy" rating and set a $360.00 target price on the stock in a report on Wednesday, January 31st. Three analysts have rated the stock with a hold rating and twelve have given a buy rating to the company's stock. According to data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and an average price target of $335.27.

Insider Activity at Stryker

In related news, Director Ronda E. Stryker sold 201,146 shares of the firm's stock in a transaction dated Monday, February 5th. The shares were sold at an average price of $342.90, for a total value of $68,972,963.40. Following the transaction, the director now owns 3,755,128 shares of the company's stock, valued at approximately $1,287,633,391.20. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. In other news, Director Ronda E. Stryker sold 201,146 shares of the stock in a transaction on Monday, February 5th. The stock was sold at an average price of $342.90, for a total transaction of $68,972,963.40. Following the transaction, the director now owns 3,755,128 shares of the company's stock, valued at approximately $1,287,633,391.20. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, CAO William E. Berry, Jr. sold 7,690 shares of Stryker stock in a transaction dated Thursday, March 7th. The shares were sold at an average price of $358.48, for a total value of $2,756,711.20. Following the completion of the sale, the chief accounting officer now owns 3,675 shares of the company's stock, valued at $1,317,414. The disclosure for this sale can be found here. Insiders sold a total of 212,109 shares of company stock worth $72,845,768 in the last quarter. 5.50% of the stock is owned by company insiders.

Stryker Price Performance

Shares of Stryker stock traded down $1.27 during trading hours on Monday, reaching $349.75. The company's stock had a trading volume of 767,774 shares, compared to its average volume of 1,280,459. The company has a debt-to-equity ratio of 0.59, a current ratio of 1.58 and a quick ratio of 0.97. Stryker Co. has a one year low of $249.98 and a one year high of $361.41. The firm has a 50 day moving average price of $349.09 and a 200-day moving average price of $308.56. The stock has a market cap of $133.07 billion, a P/E ratio of 42.55, a P/E/G ratio of 2.83 and a beta of 0.89.

Stryker (NYSE:SYK - Get Free Report) last released its quarterly earnings results on Tuesday, January 30th. The medical technology company reported $3.46 earnings per share for the quarter, beating the consensus estimate of $3.27 by $0.19. The company had revenue of $5.82 billion for the quarter, compared to analyst estimates of $5.60 billion. Stryker had a return on equity of 22.99% and a net margin of 15.44%. Stryker's quarterly revenue was up 11.8% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $3.00 EPS. On average, analysts predict that Stryker Co. will post 11.86 EPS for the current year.

Stryker Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, April 30th. Investors of record on Friday, March 29th will be paid a dividend of $0.80 per share. This represents a $3.20 dividend on an annualized basis and a dividend yield of 0.91%. The ex-dividend date is Wednesday, March 27th. Stryker's dividend payout ratio is currently 38.79%.

Stryker Profile

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.